Literature DB >> 19714717

High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?

Roger W Chapman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19714717     DOI： 10.1002/hep.23174

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?

Authors:  Roger W Chapman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

2.  Management of primary sclerosing cholangitis.

Authors:  Holger H Lutz; Jens Jw Tischendorf
Journal:  World J Hepatol       Date:  2011-06-27

3.  D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress.

Authors:  Shuang-Shuang Zhao; Na-Ren Li; Wu-Li Zhao; Hong Liu; Mao-Xu Ge; Yi-Xuan Zhang; Long-Yin Zhao; Xue-Fu You; Hong-Wei He; Rong-Guang Shao
Journal:  Acta Pharmacol Sin       Date:  2017-07-27       Impact factor: 6.150

Review 4.  Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.

Authors:  Francesca Saffioti; Kurinchi Selvan Gurusamy; Neil Hawkins; Clare D Toon; Emmanuel Tsochatzis; Brian R Davidson; Douglas Thorburn
Journal:  Cochrane Database Syst Rev       Date:  2017-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.